Injection of mANK-101 i.t. into the primary tumor both reduced formation of spontaneous lung metastases in an orthotopic 4T-1 model and led to delays or regressions of noninjected tumors in dual-flank MC38 or B16F10 models, especially when combined with systemic checkpoint blockade. The gene discussed is ANKH; the disease is neoplasm.